The use of ibuprofen as an anti-seizure medication: a systematic review
, , e
22 mag 2024
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Review paper
Pubblicato online: 22 mag 2024
Pagine: 3 - 8
Ricevuto: 01 mar 2024
Accettato: 29 apr 2024
DOI: https://doi.org/10.2478/joepi-2024-0001
Parole chiave
© 2024 Ariel Tristan et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1.

Figure 2.

Summary of article selection results
1. | Experimental | 48 male Sprague-Dawley rats | 200 mg/kg and 400 mg/kg ibuprofen injection intraperitoneally 30 minutes before disease induction | Pentylenetetrazole 35 mg/kg intraperitoneally | Reduced spike percentage in EEG, Racine Convulsion Score and low first myoclonic jerk | |
2. | Experimental | 60 male Sprague-Dawley rats | 30 mg/kg ibuprofen injection intraperitoneally 30 minutes before disease induction | Pentylenetetrazole 35 mg/kg intraperitoneally | Reduced, number, grade, latency, shortened duration of seizures and number of small amplitude spikes and spine slow waves in EEG | |
3. | Experimental | 64 male Sprague-Dawley rats | 30 mg/kg ibuprofen injection intraperitoneally 30 minutes before disease nduction | Pentylenetetrazole 35 mg/kg intraperitoneally | Reduced frequency, latency and duration of seizures |